A Fisherman Walking Across the Dry Bed of the Amazon River 

In 2023, parts of the Amazon experienced an extreme drought, the worst in over a century. Communities affected by the drought lost access to drinking water, transportation, and other necessities of daily life.

This was a Regional Winner (South America) from the World Press Photo Contest.

“This image encapsulates the undeniable reality of the environmental crisis and drought in the Amazon,” wrote the jury. “Organic and captured at the perfect moment, its composition powerfully conveys the gravity of the situation. Standing alone, it serves as a powerful representation of the challenges facing the Amazon and their global effects.”

Continue Reading

Central American Modernism, the book that Suzanne Snider and I wrote and published two years ago, is still getting “noticed” by smaller art publications

This is from Palm Beach ArtsPaper.

Ed. Note: Readers of this blog get a 40% discount off the $259 list price of Central American Modernism. That makes your cost $150 (which includes free shipping in the USA). To order your copy, go to Centralamericanmodernism.com and enter the discount code msave40.

Continue Reading

Meryl Nass: Why I’m a Fan 

Dr. Meryl Nass is a board-certified internist and a biological epidemiologist with more than 40 years of experience in the medical field. Click here to see her very impressive CV.

As a reader of this blog, you probably recognize her name. I’ve linked to her many times in the past, because when it comes to writing with authority about vaccines – and the COVID vaccine in particular – she is one of the best. And by that, I mean one of three or four epidemiological experts in the world writing about COVID and the COVID vaccines whose opinions make sense to me.

When I began reading her daily posts (there are sometimes two or three) about two years ago, I thought she might be some sort of kook. Who but a megalomaniac could devote so much time to one subject?

And I wasn’t alone. She has been continuously accused by “fact-checking” organizations (whose funding is never disclosed) of making misleading statements and causing the public to be wrongly fearful of the vaccines she warns against.

The accusations were concerning. Still, I couldn’t help but be astounded by the amount of detailed research she does. And despite my earliest reservations, I found myself being won over by the quality and quantity of evidence she provides for her claims.

I was also impressed by her emotional strength in enduring and resisting the criticism against her, including professional censures and lawsuits, and how she’s been able to keep her readers updated on her struggles in an even-handed, almost objective way. She has learned how to make very direct and sometimes very serious statements about the vaccines, the manufacturers of the vaccines, and the political and media behemoths that are promoting the vaccines without going beyond the boundaries of what she can prove with voluminous scientific data.

I began as a skeptic. But now I’m a fan.

Which is why I am very interested in and hopeful about the approach she has been using to defend herself against media and regulatory attacks. Rather than dealing with them privately through lawyers, she has been taking them public by publishing the charges against her almost as soon as they are made (often on the same day) in one of her daily posts. She prints the accusation and responds to it in detail so that her tens of thousands of readers can get the facts from the source.

This seems to me to be a bit risky because it must embarrass and infuriate those that are trying to shut her up and shut her practice down. But I’m hoping that because she has so many followers, she will be able to wage her battle both within the jurisdictions that govern the complaints and in a public forum where those of us that are interested in COVID and the COVID vaccines can see exactly how the massive pro-vaccine forces work.

Here’s a recent example. Some guy named “John Gregory,” who calls himself a “health editor” for a group called NewsGuard, which, he says, “reports on and tracks online misinformation,” sends her an email accusing her of making misleading statements… and tells her that his deadline for publishing her response is virtually the next day. (This is a common unethical journalistic practice. And, by the way, I checked into NewsGuard. They are hardly objective. Just another left-wing partisan group claiming to be interested in facts.)

Here’s what he wrote:

Dr. Nass,

I’m emailing in regards to your April 20, 2024, CHD video in which you cited the FDA package insert for the H5N1 vaccine Audenz, and said, “One in 200 people who got this vaccine in a clinical trial died,” and later added, “This is a dangerous vaccine for a nothing disease.”

Video of your remarks has begun circulating widely on social media platforms in the past two weeks, used as evidence for claims like “Dr. Meryl Nass: One of the approved Bird Flu quackccines, Audenz… had a death rate of 1 in 200 during clinical trials.”

I noticed the screenshot included in your original video highlighted the sentence, “Fatal SAEs [Serious Adverse Events] included 11 (0.5%) Audenz recipients and 1 (0.1%) placebo recipients,” even though the very next sentence said, “No SAEs were assessed as being related to Audenz,” meaning that none of the reported serious adverse events – including deaths – that occurred among trial participants were caused by the vaccine.

You also did not mention that the FDA’s own statistical review of Audenz stated that, “No deaths occurred that were considered related to the vaccine,” and concluded, “No major statistical or safety issues have been identified” with the vaccine, or that the published results of the Audenz trial said: “None of the serious AEs or AEs of special interest reported by subjects who received aH5N1c were considered vaccine related. Two subjects in the placebo group reported a related AE of special interest (immune thrombocytopenic purpura and polymyalgia rheumatic); these events were also considered serious AEs. During the study, 12 (0.4%) subjects had serious AEs with a fatal outcome, none of which were attributed to the study treatment, and most (n = 11) occurred after Day 43 during the follow-up period in subjects ≥65 years with underlying severe comorbidities and multiple concomitant medications.”

Is there any reason why you did not mention any of this countervailing information?

My deadline is 5pm eastern today, July 3. Thank you.

Best regards,
John Gregory

 

Gregory’s goal, of course, was to discredit her by saying something like, “We contacted Ms. Nass to give her a chance to refute these charges but she did not respond.”

But Nass, being a veteran of these sorts of sleazy tactics, responds immediately with a massive amount of proof to back up what she had said – then thanks him for “the opportunity to clarify the information so that your readers will be fully informed.”

To wit:

Dear Mr. Gregory,

Since I provided a screenshot of the package insert of the Audenz licensed vaccine and repeated what it said, this can hardly be characterized as misinformation, which you claim to be investigating. Since I included the next sentence in the presentation, it cannot even be construed as incomplete.

Had you been working on issues of vaccines for over 25 years as I have, you would have been aware that the sponsor (mfr) and FDA, who together craft the vaccine labels aka package inserts, ALWAYS assert that most or all of the deaths and serious adverse events occurring during a clinical trial were adjudged to be not due to the vaccine. Had they judged otherwise, a license would probably not have been issued. A license was issued for Audenz.

Later, when a vaccine is given to millions of people, not just a few hundred as in this case, one learns which side effects are IN FACT attributable to the vaccine.

For example, at least a hundred million Americans had received an mRNA COVID vaccine before it was determined to cause myocarditis, in late May of 2021 by FDA.

That is the reason why the raw data, which I presented, are important. So that people have the information to judge for themselves what risks they may face when choosing vaccination. In fact, clinical trials often exclude sick subjects, and drugs and vaccines almost invariably appear more safe and effective in clinical trial data than they do later, in the real world – a fact known to all medical researchers.

Why did I not mention material from an article? Because I was referring to the Audenz label, which is the legal document that FDA attests is true, unlike published articles which are generally written by the vaccine sponsor and have a lesser degree of reliability. In fact, the numbers in the article versus those in the label are not exactly the same.

Furthermore, if the US government was comfortable with the H5N1 Audenz vaccine, why did DHHS’ BARDA just place an order with Moderna for H5N8 mRNA vaccines, even though the avian flu circulating in the US is H5N1? Even though it makes much more sense to match the neuraminidase portion of the vaccine to the circulating strain… which is done every year when seasonal influenza vaccines are produced?

Finally, I invite you to take a look at the WHO data on deaths in humans worldwide from the H5N1 bird flu, which confirms it is a nothing disease in humans, having mutated to a different form than it once had. The federal health agencies have monitored 9,000 farm workers and all they found were 4 mild cases of disease, no hospitalizations and no deaths in the US over the past several years.

I appreciate you giving me the opportunity to clarify the information so that your readers will be fully informed.

Meryl Nass

 

End result: Not only did she make it impossible for him to claim that she was unable to answer his (invalid) charges, she exposed his chicanery before his supposed publishing deadline.

I hate the expression, “You go, girl!” But I’ll say it for Meryl Nass.

Continue Reading

I Did It! 

On Saturday, I gave my presentation on “the seven natural laws of wealth building” to an audience of about 1,000 plus another 700 watching the live stream. I won’t grade my performance. Everyone I spoke to later was highly complimentary, but in my experience the Japanese are always complimentary, so I won’t present that as evidentiary.

What I can tell you is that the way my Japanese partners and the hotel staff treated me was absurdly flattering. Throughout the day, I was escorted by at least a half-dozen people who took me through hidden hallways and back staircases and into various “green rooms” and then eventually onto the various stages and platforms I was speaking from – all done, apparently, to “protect me” from my “fans.”

I’m not kidding.

After my three-hour keynote speech, I spent another two hours doing interviews, and then two full hours with 120 individual ticket holders who had paid some crazy additional sum of money to have their photos taken with me and Sean (who runs the business my family has with the Japanese). And after that, there was a cocktail party, where Sean and I separately (each with our own simultaneous translator) visited 11 or 12 tables of about six to eight people each and were given seven minutes to answer their questions before a handler dragged us and our translators to another table.

The next day was devoted to 20 of the 120 who had paid $5,000 each to spend the day with us and listen to our ideas about business, entrepreneurship, and wealth-building. They all had questions, and I had been asked to spend 20 minutes on answering each one. At 20 people times 20 minutes, it took about seven hours.

It was exhausting but energizing, because almost all of the 20 were successful or promising business owners and professionals and the questions were good. They not only asked about business, investing, retirement, and estate planning (which I had expected), but also about American politics, geopolitics, macroeconomics, currencies, cryptocurrencies, real estate investing, art collecting, personal productivity, physical fitness, sleeping habits, child rearing… and I can’t remember what else.

The next day (Monday for me, Sunday for you), I spent another six hours with a different group of people – 100 members of a private wealth education club I had started 14 years ago in the USA, which was now in its second year in Japan. That was an entirely different experience because the crowd was considerably younger and their interests were more in the realm of entrepreneurship and business management.

The final two hours, which could have been a disaster, turned out to be the highlight of the three days, both for me and, I think, the 100 members of the club. My challenge was to answer all of their questions in the 120 minutes we had left after my presentation – which meant that even if each person limited their questioning to 30 seconds, I would have only 30 seconds to respond.

Well, they did, for the most part, limit their questioning to 30 seconds or less, and I was able to answer them in an average of 30 seconds. Which was, as surprising as it may sound, completely fun and exciting.

After one final dinner with my partner, his family, and Miki, my ever-present and super-considerate translator, I was back to the hotel at 10:30 and asleep by 10:45.

That’s the quick recap. There’s a whole lot of other things that happened and lots of interesting thoughts I’ve had about Japan, its culture, and how Americans can profit from it. I’ll tell you more about all that in the coming weeks.

Continue Reading

Is AI and Robotics Really a Big Thing? Or Is It Just Another Technological Innovation That Will Have Little Impact on Our World? 

We’ve long accepted the idea that the rapid development of AI and robotics will soon be putting millions of truck drivers, warehouse workers, train conductors, customer service agents, and delivery people out of work. What isn’t as frequently talked about is how it will destroy many more millions of white-collar and professional jobs, such as accountants, actuaries, insurance adjusters, telephone salespeople, librarians, bill collectors, dog walkers, marketers, advertising copywriters, quality control officers, personal recruitment officers, human resource directors, financial analysts, software developers, diagnosticians and repair people. Also legal aids and most lawyers, nurses and most doctors, teaching assistants and most teachers…

Can I stop there?

Well, no, I can’t. Because that list doesn’t include another class of workers that I believe will almost certainly be replaced in the next five to 10 years – a replacement that you might think unlikely because these people do the sort of jobs for which the core requirement is being human.

Yes, flesh and blood nurses will be replaced by more efficient and more attentive non-human nurses that will provide 200% better care with 99% fewer errors. But AI and robotics will also eventually replace caregivers, social workers, marriage counselors, conflict dispute experts, spiritual advisers, life coaches, motivational speakers and coaches, and even psychologists and psychiatrists.

Some of these transformations are already underway. But I believe the advantages of AI and robotic labor over human labor are so great that the technological innovations to move it forward will be faster than most people can even imagine. It will be Moore’s Law on crack.

If you think I’m crazy, you may be interested to know this: Several tech companies have already developed and are testing AI/robotics actor/models – beauty-pageant-level avatars that compete for cash prizes and then get contracts with businesses as “ambassadors” of their brands.

I know. This is straight out of the 1985 movie Weird Science, where two teen nerds create a virtual woman on a computer and a freak electrical accident brings her to life. The possibility of that actually happening may have seemed like a ludicrous invention of fiction when the movie came out… but here we are nearly 40 years later.

And don’t kid yourself about avatars being rejected by consumers because they aren’t really real. I’ve seen at least a dozen studies conducted in the last 12 to 24 months that show that even when consumers can ascertain the difference between an avatar and a human actor/model, they don’t care!

I sometimes fear that K saves her most important worries, dreams, and confessions – the ones I’ve always felt privileged to be included in – with Siri and Alexa!

Okay, I’m kidding about that. But I’m not kidding when I say that I believe that by 2030 the world we live in today will have been transformed so radically that young people will look back at 2024 as we look back at the pre-industrialized world of the 17th and 18th centuries.

Continue Reading

Chart of the Week: Retail Declines Again 

Before I read Sean’s piece for this week’s issue, I was looking at retail numbers myself. I was wondering why the data was still largely positive when so many of my friends and acquaintances in the retail field are feeling like sales are slowing down.

At the same time, there are still more retail jobs open than are being filled. That again feels wrong to me. I don’t doubt the data, but I wonder if the scarcity of job hunters isn’t because millions of formerly employed workers are still hanging out, spending the last of the cash they received from the COVID bailouts and stimulus packages that the Biden administration enacted.

As you will see from his comments, Sean has a better grasp of this sort of data than I do. But when my personal sources are giving me the same sort of cautionary signals that Sean sees in the numbers, it leaves me wondering when the bill is going to be paid. – MF

I’m going to start calling it the “slow roll recession.”

Signs of US economic weakness keep appearing in the data. Taken individually, none of it feels particularly scary. But added up, we have a pretty strong reason to worry.

Here’s the latest thing I’ve seen that has me mildly concerned: Inflation-adjusted retail sales fell 0.9% in May and are currently about $15 billion below their April 2021 peak.

Right now, if this trend continues, we’re on track for a retail recession, with two consecutive quarters of year-over-year declines.

US recessions are labeled in gray in the chart above, and you can see how retail recessions are often a precursor to broader economic recessions.

That’s because consuming products and services makes up about 70% of US GDP. And retail sales account for nearly 40% of consumption.

Retail sales are like a canary in the coal mine. If they drop dead, you know we’re in trouble.

So should we be worried right now?

Well, if the American economy had a tachometer, the engine’s not running in the red yet – but lots of data suggests we’re somewhere in the yellow “warning” zone.

There’s another measure I’m watching closely, which is the ratio between retail inventory value and sales.

We sometimes don’t know we’re in a recession until months after a recession has begun.

But what we do know is that, when recessions occur, people stop buying stuff. Sales go down while inventory piles up.

Hence, we see big spikes in the Inventory/Sales ratio during recessions.

And we’re just not seeing that yet. Though “yet” is doing a lot of heavy lifting in that previous sentence.

So what should investors do?

Well, let me tell you this. I run stock screeners looking for value plays in the market pretty much every week. A value play in the market is simply a stock that looks like it is performing better financially than its price action would suggest.

Recently, a lot of retail stocks have been showing up on my screens. Dillard’s (DDS) for example. Dillard’s financial performance up to now has been exceptional… their price action, also exceptional… their valuation based on historical fundamentals, extremely attractive.

But what has happened tells us nothing about what will happen.

If American consumption is starting to sputter and there’s a risk that it starts to plummet as prohibitive cost inflation and high debt take their toll?

Retail stocks that don’t sell essentials are probably the last place you want to be as an investor.

So be careful out there.

– Sean MacIntyre

Check out Sean’s YouTube channel here.

Continue Reading

Five Quick Bites 

* Interesting. Elon Musk on the Hamas-Israel confrontation. Click here.

* Interesting. Between 2000 and 2024, food experienced an average inflation rate of 2.83% per year. In other words, an equivalent purchase of food that cost $20 in the year 2000 would cost $39.08 in 2024.

* Fun and Interesting. Someone is paying for their education?!?!! Click here.

* Interesting. Good and bad fats. Is there a difference? Click here.

* Fun and Interesting. Watch this professional kayaker go over an Arctic waterfall in his solo watercraft.

Continue Reading

Prize Winners from the 24th Annual Hampton Beach Sand Sculpture Classic 

First prize of $6,000 went to David Ducharme for this sculpture – “Sofia’s Cradle” – depicting the Greek goddess of wisdom. The cradle beneath her resembles a nest, “a space,” Ducharme explained, “where wisdom gets nurtured.”

Click here to see and read about all of the winners.

Continue Reading